Deep Medicine Acquisition Corp. (DMAQ) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Deep Medicine Acquisition Corp. (DMAQ:NASDAQ), powered by AI.
- Current Price
- $1.35
- P/E Ratio
- -44.7
- Market Cap
- 18M
- Sector
- Financial Services
What is the Deep Medicine Acquisition Corp. stock price forecast?
Deep Medicine Acquisition Corp. is currently trading at $1.35. View real-time AI analysis on Alpha Lenz.
What is Deep Medicine Acquisition Corp. insider trading activity?
View the latest insider trading data for Deep Medicine Acquisition Corp. on Alpha Lenz.
What is Deep Medicine Acquisition Corp.'s P/E ratio?
Deep Medicine Acquisition Corp.'s P/E ratio is -44.7.
Deep Medicine Acquisition Corp.
NASDAQ · DMAQ“Deep Medicine Acquisition Corp. trades at a P/E of -44.7 (undervalued) with modest ROE of -0.6%.”
Ask for details →Company Overview
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. Deep Medicine Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Deep Medicine Acquisition Corp. operates as subsidiary of Bright Vision Sponsor LLC.
Company Statistics
FY 2023Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Deep Medicine Acquisition Corp. trades at a P/E of -44.7 (undervalued) with modest ROE of -0.6%.”
Ask for details →Frequently Asked Questions
Deep Medicine Acquisition Corp. (ticker: DMAQ) is a company listed on NASDAQ in the Financial Services sector (Shell Companies). Market cap is $18M.
The current price is $1.35 with a P/E ratio of -44.73x and P/B of 7.01x.
ROE is -0.63%.